4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001104659-20-045926
Director bought 64,000 shares at $2.43 ($155,264)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schwartz Aharon Director | 2020-04-07 | Purchase | +64,000 | $2.43 | $155,264 | 64,000 | D |
| Open-market purchases · 64,000 sh · avg $2.43 · $155,264 | |||||||
Loading xslF345X03/tm2015785d1_4.xml…